No-reflow following dilatation of a coronary lesion with a large lipid core

Circulation Journal

Volumn 66, Issue 7, 2002, Pages 702-704

  Jun ichi, Kotani ^a   Shinsuke, Nanto ^a   Masafumi, Kitakaze ^b   Tomoki, Ohara ^a   Takakazu, Morozumi ^a   Tetsuya, Watanabe ^a   Masashi, Fujita ^a   Masatsugu, Hon ^b   Seiki, Nagata ^a  

^a KANSAI ROSAI HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atheromatous plaque; Lipid core; No reflow; Percutaneous transluminal coronary angioplasty (PTCA)

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CASE REPORT; CINEANGIOCARDIOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID COMPOSITION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; THROMBECTOMY; TRANSLUMINAL CORONARY ANGIOPLASTY; ATHERECTOMY; BLOOD FLOW VELOCITY; CORONARY ARTERY ATHEROSCLEROSIS; HEART INFARCTION; MACROPHAGE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

CHOLESTEROL; LIPID;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY, CORONARY; BLOOD FLOW VELOCITY; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; HUMANS; LIPIDS; MACROPHAGES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 0036303372     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.702     Document Type: Article

References (8)

1. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review: A meta analysis
2. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention
3. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty
4. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty
5. The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no reflow phenomenon during coronary reperfusion
6. Mechanisms of arterial thrombosis: Foundation for therapy
7. Disappearance of the 'No-Reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction
8. Lack of clinical efficacy of pharmacologic treatment of the no-reflow phenomenon despite significant angiographic improvement